4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hypertryptophanemia due to tryptophan 2,3-dioxygenase deficiency

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this report we describe the first human case of hypertryptophanemia confirmed to be due to tryptophan 2,3-dioxygenase deficiency. The underlying etiology was established by sequencing the TDO2 gene, in which there was compound heterozygosity for two rare variants: c.324G>C, p.Met108Ile and c.491dup, p.Ile165Aspfs*12. The pathogenicity of these variants was confirmed by molecular-level studies, which showed that c.491dup does not produce soluble protein and c.324G>C results in a catalytically less efficient Met108Ile enzyme that is prone to proteolytic degradation. The biochemical phenotype of hypertryptophanemia and hyperserotoninemia does not appear to have significant clinical consequences.

          Related collections

          Author and article information

          Journal
          9805456
          20853
          Mol Genet Metab
          Mol. Genet. Metab.
          Molecular genetics and metabolism
          1096-7192
          1096-7206
          18 March 2017
          01 March 2017
          April 2017
          01 April 2018
          : 120
          : 4
          : 317-324
          Affiliations
          [a ]Division of Medical Genetics, Alberta Children’s Hospital
          [b ]Department of Chemistry, University of Texas at San Antonio, San Antonio, TX. USA
          [c ]Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton AB Canada
          [d ]Department of Medical Genetics, University of Alberta, Edmonton AB Canada
          [e ]Departments of Pediatrics and Community Health Sciences, University of Calgary, Calgary AB. Canada
          [f ]Department of Chemistry, Georgia State University, Atlanta, GA, USA
          Author notes
          [* ]To whom correspondence may be addressed. patrick.ferreira@ 123456ahs.ca or Feradical@ 123456utsa.edu
          [1]

          P.F. and I.S. contributed equally to this work.

          [2]

          Current address: Department of Chemistry, University of Chicago, Chicago, IL 60637, USA.

          Article
          PMC5421356 PMC5421356 5421356 nihpa858813
          10.1016/j.ymgme.2017.02.009
          5421356
          28285122
          ac5992d4-5a8d-45aa-aef0-fd0d6d8a2b6e
          History
          Categories
          Article

          hypertryptophanemia,hyperserotoninemia,tryptophan 2,3-dioxygenase, TDO2

          Comments

          Comment on this article